Ad
Monday, 12 December 2016
Exclusive: Lonza says in talks to buy Capsugel; deal could top $5 billion - sources
(Reuters) - Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment